Skip Navigation LinksHome > Professional Development > eLearning > New Developments in PLT TXN Safety (PRT, Secondary Testing “7-day Platelets”)

New Developments in PLT TXN Safety (PRT, Secondary Testing “7-day Platelets”)

Please note: AABB reserves the right to make updates to this program.

Wednesday, April 19, 2017- [Rescheduled from 2/22/17]
2:00 – 3:30 PM (ET) 7:00 – 8:30 PM (GMT)
Master Program Number: 112 (see program format numbers below under Registration)

Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Physicians, Scientists, Technologists, Nurses, Managers/Supervisors, CEOs, CFOs, Laboratory Staff, Medical Directors, Students/Fellows, Residents, Hospital Blood Banks
Teaching Level: Intermediate

Director/Moderator: Angela Dirr, Senior Director of Donor Care, Blood Systems, Inc., Denver, CO
Speakers: Sarah Harm, MD, MS, Medical Director, Assistant Professor of Pathology, University of Vermont Medical Center, University of Vermont College of Medicine, Burlington, VT; Kadi Schroeder, RN, BSN, MBA, Director of Ancillary Services, Bonfils Blood Center, Blood Systems, Denver, CO; Tiffany Burnett, MS, Director of Production, Bonfils Blood Center, Blood Systems, Denver, CO; Deanna Pike, Manager of Markets and Strategic Development, Bonfils Blood Center, Blood Systems, Denver, CO

Learning Objectives

After participating in this educational activity, participants should be able to:

7-day Platelet:

  • Discuss the history of 7-day platelets in the US and the FDA draft guidance for industry.
  • Understand logistics, safety and labeling considerations for implementing 7-day platelets.
  • Describe a hospital based transfusion service implementation plan for 7-day platelets.

PRT

  • Discuss the benefits to implementing PRT platelets.
  • Identify how to balance supply and demand of platelets when implementing PRT.
  • Discuss the support received from the vendor in order to implement efficiently and effectively.
  • Identify tactics on introducing a new product line to hospital clients.

Program Description

The program will be presented in two parts: secondary Testing – 7-day platelets and PRT. Secondary testing will discuss 7-Day platelets as described by the FDA and the AABB Standards, will illustrate the bacterial screening test used to extend the outdate of platelets and describe the logistics of 7-Day platelet implementation into a hospital-based transfusion service. As PRT is being introduced to the blood industry, blood centers need to make a decision on whether or not this technology will work for their manufacturing process and if their clients want this product. The speakers will review the benefits to PRT platelets and how Bonfils Blood Center managed to relay these benefits to hospital clients. Discussions regarding supply and demand will be a highlight as blood centers implementing PRT must consider a dual inventory and the impact to their clients when manufacturing a dual product line. The speakers will review how Bonfils Blood Center utilized resources available from the vendor to assist with implementation and marketing.

Registration

  Program #
Single Viewer: LiveRegister17EL-2035-112
Single Viewer: On-DemandRegister17EL-4035-112
Group Viewing: LiveRegister17EL-6035-112
Group Viewing: On-DemandRegister17EL-8035-112
Group Viewing: Live & On-DemandRegister17EL-9935-112

Speaker Biographies

Dr. Sarah Harm is the medical director of the Blood Bank at University of Vermont Medical Center in Burlington, VT. She completed her fellowship in Blood Bank/Transfusion Medicine in Pittsburgh, PA at the Institute for Transfusion Medicine. Sarah is originally from Nazareth, PA and spent many years between Boston, MA and Philadelphia, PA for education and work in the pharmaceutical industry.

Kadi Schroeder is currently the Director of Ancillary Services at Bonfils Blood Center where she manages the Donor Relations, Specialized Donations, and Donor Qualification departments. In her 17 years of service to Bonfils, Kadi has tirelessly implemented numerous new projects and processes for the organization with a keen eye on continuous improvement, including a Malaria Travel Program, uDHQ, Electronic Donation Record, and implementation of newly detected infectious disease and patient safety screening tests. She has also implemented new products and services including Pathogen Reduced platelets, immunotherapy collections, as well as expanding the research opportunities at Bonfils. Kadi has bachelor of science degree in nursing and a Master’s degree in business administration from the University of Colorado in Denver.

Tiffany Burnett is currently the Director of Production and Equipment Management at Bonfils Blood Center and has worked in this department for the last year. For the previous ten years, she was the Director of Business Development, responsible for donor recruitment activities and managing the mobile recruiters and Appointment Center telerecruiters. As a result of her two roles, her project involvement includes: implementation of Pathogen Reduced platelets; targeted growth for both platelets and O-negative RBCs; donor retention, and cryo production process improvement. Tiffany has a bachelor of science degree in Marketing from the University of Colorado – Boulder and a Master’s degree in Organizational Leadership from Colorado State University – Global Campus.

Deanna Pike is currently the Manager of Markets and Strategic Development at Bonfils Blood Center. She has worked in the Client Development Department for just over a year and has had 5 years of experience working in the healthcare sector. She manages market research, client facing marketing activities, and analysis to drive process improvement and value added services for clients. She assists in the creation of the strategic plan for Blood Systems, Inc. and helps identify tactics necessary to foster a sustainable environment for their lifesaving mission. She has a bachelor of science in Business Management from Purdue University.